Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients
Gespeichert in:
| Veröffentlicht in: | Journal of acquired immune deficiency syndromes (1999) 2001-02, Vol.26 (2), p.191-193 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 193 |
|---|---|
| container_issue | 2 |
| container_start_page | 191 |
| container_title | Journal of acquired immune deficiency syndromes (1999) |
| container_volume | 26 |
| creator | Hänsel, Alexander Bucher, Heiner C Nüesch, Reto Battegay, Manuel |
| description | |
| doi_str_mv | 10.1097/00042560-200102010-00016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76958722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76958722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3684-b2091ff0ef88e7fd7f003148a6058bd5f1c849c0bd84fca6b925733e446dba2f3</originalsourceid><addsrcrecordid>eNpdkt1u1DAQhS0EoqXwCsg3cGfqvyTO5Wqh7EpVqarCbeQ4Y2LI2ovttNpH6FvjZZdW6oU1lvWdORqfQQgz-onRtjmnlEpe1ZRwShnl5ZDyxOoX6JS1UpJGKfmy3CteEclEdYLepPRrT0jZvkYnjHHJmWpP0cMN6BR8wjZE_NklE3x2ftbZBY-DxRcupoxX7uc47fDCZHcHeFGQCDmGOxf1hG9HiHq7w85jjZdhDDHvldcxZHBeJ8BrP7re5RDJld43WK1_kLW3YDIM-Lp4gc_pLXpl9ZTg3bGeoe8XX26XK3L57et6ubgkRtRKkp7TlllLwSoFjR0aS6lgUumaVqofKsuMkq2h_aCkNbruW141QoCU9dBrbsUZ-njou43hzwwpd5syNkyT9hDm1DV1W6mG8wKqA2hiSCmC7bbRbXTcdYx2-xi6_zF0jzF0_2Io0vdHj7nfwPAkPP57AT4cAZ2MnmzU3rj0xElWM9E2hZMH7j5MGWL6Pc33ELsR9JTHYsZ4LYR8tgZS_AWNGqDx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76958722</pqid></control><display><type>article</type><title>Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><source>Free E- Journals</source><creator>Hänsel, Alexander ; Bucher, Heiner C ; Nüesch, Reto ; Battegay, Manuel</creator><creatorcontrib>Hänsel, Alexander ; Bucher, Heiner C ; Nüesch, Reto ; Battegay, Manuel</creatorcontrib><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/00042560-200102010-00016</identifier><identifier>PMID: 11242189</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins, Inc</publisher><subject>AIDS/HIV ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiretroviral Therapy, Highly Active ; Antiviral agents ; Biological and medical sciences ; Cohort Studies ; Fundamental and applied biological sciences. Psychology ; HIV Infections - drug therapy ; HIV Protease Inhibitors - therapeutic use ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Microbiology ; Pharmacology. Drug treatments ; Sweden ; Treatment Failure ; Treatment Refusal ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2001-02, Vol.26 (2), p.191-193</ispartof><rights>2001 Lippincott Williams & Wilkins, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3684-b2091ff0ef88e7fd7f003148a6058bd5f1c849c0bd84fca6b925733e446dba2f3</citedby><cites>FETCH-LOGICAL-c3684-b2091ff0ef88e7fd7f003148a6058bd5f1c849c0bd84fca6b925733e446dba2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-200102010-00014$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00126334-200102010-00014$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14161397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11242189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hänsel, Alexander</creatorcontrib><creatorcontrib>Bucher, Heiner C</creatorcontrib><creatorcontrib>Nüesch, Reto</creatorcontrib><creatorcontrib>Battegay, Manuel</creatorcontrib><title>Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><subject>AIDS/HIV</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Protease Inhibitors - therapeutic use</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Sweden</subject><subject>Treatment Failure</subject><subject>Treatment Refusal</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkt1u1DAQhS0EoqXwCsg3cGfqvyTO5Wqh7EpVqarCbeQ4Y2LI2ovttNpH6FvjZZdW6oU1lvWdORqfQQgz-onRtjmnlEpe1ZRwShnl5ZDyxOoX6JS1UpJGKfmy3CteEclEdYLepPRrT0jZvkYnjHHJmWpP0cMN6BR8wjZE_NklE3x2ftbZBY-DxRcupoxX7uc47fDCZHcHeFGQCDmGOxf1hG9HiHq7w85jjZdhDDHvldcxZHBeJ8BrP7re5RDJld43WK1_kLW3YDIM-Lp4gc_pLXpl9ZTg3bGeoe8XX26XK3L57et6ubgkRtRKkp7TlllLwSoFjR0aS6lgUumaVqofKsuMkq2h_aCkNbruW141QoCU9dBrbsUZ-njou43hzwwpd5syNkyT9hDm1DV1W6mG8wKqA2hiSCmC7bbRbXTcdYx2-xi6_zF0jzF0_2Io0vdHj7nfwPAkPP57AT4cAZ2MnmzU3rj0xElWM9E2hZMH7j5MGWL6Pc33ELsR9JTHYsZ4LYR8tgZS_AWNGqDx</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Hänsel, Alexander</creator><creator>Bucher, Heiner C</creator><creator>Nüesch, Reto</creator><creator>Battegay, Manuel</creator><general>Lippincott Williams & Wilkins, Inc</general><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients</title><author>Hänsel, Alexander ; Bucher, Heiner C ; Nüesch, Reto ; Battegay, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3684-b2091ff0ef88e7fd7f003148a6058bd5f1c849c0bd84fca6b925733e446dba2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>AIDS/HIV</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Protease Inhibitors - therapeutic use</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Sweden</topic><topic>Treatment Failure</topic><topic>Treatment Refusal</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hänsel, Alexander</creatorcontrib><creatorcontrib>Bucher, Heiner C</creatorcontrib><creatorcontrib>Nüesch, Reto</creatorcontrib><creatorcontrib>Battegay, Manuel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hänsel, Alexander</au><au>Bucher, Heiner C</au><au>Nüesch, Reto</au><au>Battegay, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>26</volume><issue>2</issue><spage>191</spage><epage>193</epage><pages>191-193</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>11242189</pmid><doi>10.1097/00042560-200102010-00016</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1525-4135 |
| ispartof | Journal of acquired immune deficiency syndromes (1999), 2001-02, Vol.26 (2), p.191-193 |
| issn | 1525-4135 1944-7884 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76958722 |
| source | MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete; Free E- Journals |
| subjects | AIDS/HIV Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active Antiviral agents Biological and medical sciences Cohort Studies Fundamental and applied biological sciences. Psychology HIV Infections - drug therapy HIV Protease Inhibitors - therapeutic use Human viral diseases Humans Infectious diseases Medical sciences Microbiology Pharmacology. Drug treatments Sweden Treatment Failure Treatment Refusal Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
| title | Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor-Naive HIV-Infected Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T02%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reasons%20for%20Discontinuation%20of%20First%20Highly%20Active%20Antiretroviral%20Therapy%20in%20a%20Cohort%20of%20Proteinase%20Inhibitor-Naive%20HIV-Infected%20Patients&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=H%C3%A4nsel,%20Alexander&rft.date=2001-02-01&rft.volume=26&rft.issue=2&rft.spage=191&rft.epage=193&rft.pages=191-193&rft.issn=1525-4135&rft.eissn=1944-7884&rft_id=info:doi/10.1097/00042560-200102010-00016&rft_dat=%3Cproquest_cross%3E76958722%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76958722&rft_id=info:pmid/11242189&rfr_iscdi=true |